Results 21 to 30 of about 560,370 (324)

Peanut immunotherapy [PDF]

open access: yesClinical and Translational Allergy, 2014
AbstractPeanut allergy is common and can be a cause of severe, life‐threatening reactions. It is rarely outgrown like other food allergies, such as egg and milk. Peanut allergy has a significant effect on the quality of life of sufferers and their families, due to dietary and social restrictions, but mainly stemming from fear of accidental peanut ...
Katherine Anagnostou, Andrew Clark
openaire   +3 more sources

Modulation of Endosome Function, Vesicle Trafficking and Autophagy by Human Herpesviruses

open access: yesCells, 2021
Human herpesviruses are a ubiquitous family of viruses that infect individuals of all ages and are present at a high prevalence worldwide. Herpesviruses are responsible for a broad spectrum of diseases, ranging from skin and mucosal lesions to blindness ...
Eduardo I. Tognarelli   +6 more
doaj   +1 more source

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

open access: yesScience, 2018
Good bacteria help fight cancer Resident gut bacteria can affect patient responses to cancer immunotherapy (see the Perspective by Jobin). Routy et al. show that antibiotic consumption is associated with poor response to immunotherapeutic PD-1 blockade ...
V. Gopalakrishnan   +69 more
semanticscholar   +1 more source

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

open access: yesNature, 2021
Hepatocellular carcinoma (HCC) can have viral or non-viral causes1–5. Non-alcoholic steatohepatitis (NASH) is an important driver of HCC. Immunotherapy has been approved for treating HCC, but biomarker-based stratification of patients for optimal ...
D. Pfister   +109 more
semanticscholar   +1 more source

Sarcoma Immunotherapy [PDF]

open access: yesCancers, 2011
Much of our knowledge regarding cancer immunotherapy has been derived from sarcoma models. However, translation of preclinical findings to bedside success has been limited in this disease, though several intriguing clinical studies hint at the potential efficacy of this treatment modality.
Gouw, Launce G   +3 more
openaire   +2 more sources

Neoantigens in cancer immunotherapy

open access: yesScience, 2015
The clinical relevance of T cells in the control of a diverse set of human cancers is now beyond doubt. However, the nature of the antigens that allow the immune system to distinguish cancer cells from noncancer cells has long remained obscure.
T. Schumacher, R. Schreiber
semanticscholar   +1 more source

The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications

open access: yesCellular & Molecular Immunology, 2020
Immunotherapy has revolutionized cancer treatment and rejuvenated the field of tumor immunology. Several types of immunotherapy, including adoptive cell transfer (ACT) and immune checkpoint inhibitors (ICIs), have obtained durable clinical responses, but
Yuanyuan Zhang, Zemin Zhang
semanticscholar   +1 more source

Ex vivo engineered human plasma cells exhibit robust protein secretion and long-term engraftment in vivo

open access: yesNature Communications, 2022
Plasma B cells (PC) are a potential source for protein replacement as they could be engineered to secrete protein other than antibody. Here the authors engineer B cells to express exogenous proteins and demonstrate that these cells can persist long term ...
Rene Yu-Hong Cheng   +11 more
doaj   +1 more source

Immunotherapy for osteosarcoma [PDF]

open access: yesHuman Vaccines & Immunotherapeutics, 2020
Osteosarcoma (OS) is the most common malignant bone tumor and often occurs in children. Chemotherapy with methotrexate, cisplatin, doxorubicin, and ifosfamide has greatly improved the prognosis of patients with OS, and most patients have been able to preserve their limbs.
Yoshihiro Matsumoto, Kenichiro Yahiro
openaire   +3 more sources

Immunotherapy for thymoma [PDF]

open access: yesJournal of Thoracic Disease, 2020
Thymic epithelial tumors (TETs) are rare thymic neoplasms. There are approximately 1.5 cases per million TETs per year. They are the most common anterior mediastinal tumors in adults. Due to limited activity of available treatment options novel strategies and treatment options are needed and treatment with immune checkpoint inhibitors is an attractive ...
Kristina Krpina   +7 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy